Vol 41 # 3 September 2009 - Kma.org.kw

214
Mode of Detection of Transvenous Defibrillation Lead Malfunction in Implantable Defibrillators
September 2009
2. Stevens J, Buchwald AB, Krieglstein H, Unterberg
C. Early detection of lead fracture by painless
high voltage lead impedance measurement in
a transvenous ICD lead system. J Interv Card
Electrophysiol 2000; 4:269-272.
3. Ellenbogen KA, Wood MA, Shepard RK, et al. Detection
and management of an implantable cardioverter
defibrillator lead failure: incidence and clinical
implications. J Am Coll Cardiol 2003; 41:73-80.
4. Luria D, Glikson M, Brady PA, et al. Predictors and
mode of detection of transvenous lead malfunction
in implantable defibrillators. Am J Cardiol 2001;
87:901-904.
5. Gallik DM, Ben-Zur UM, Gross JN, Furman S. Lead
fracture in cephalic versus subclavian approach with
transvenous implantable cardioverter defibrillator
systems. Pacing Clin Electrophysiol 1996; 19:1089-1094.
6. Kleemann T, Becker T, Doenges K, et al. Annual
rate of transvenous defibrillation lead defects in
implantable cardioverter-defibrillators over a period
of > 10 years. Circulation 2007; 115:2474-2480.
7. Gunderson BD, Patel AS, Bounds CA, Shepard RK,
Wood MA, Ellenbogen KA. An algorithm to predict
implantable cardioverter-defibrillator lead failure. J
Am Coll Cardiol 2004; 44:1898-1902.
8. Kitamura S, Satomi K, Kurita T, et al. Long- term
follow-up of transvenous defibrillation leads: high
incidence of fracture in coaxial polyurethane lead.
Circ J 2006; 70:273-277.
9. Renzulli A, Vitale N, D’Onofrio A, Cotrufo M.
Implantable cardioverter defibrillator malfunction
due to transvenous lead insulation break. Pacing Clin
Electrophysiol 1994; 17:245-246.
10. Schwacke H, Drogemuller A, Siemon G, et al. Leadrelated
complications in 340 patients with an implantable
cardioverter/defibrillator. Z Kardiol 1999; 88:559-565.
11. Roelke M, O’Nunain SS, Osswald S, Garan H, Harthorne
JW, Ruskin JN. Subclavian crush syndrome complicating
transvenous cardioverter defibrillator systems. Pacing
Clin Electrophysiol 1995; 18:973-979.
12. Kron J, Herre J, Renfroe EG, et al. Lead- and devicerelated
complications in the antiarrhythmics versus
implantable defibrillators trial. Am Heart J 2001; 141:92-
98.
13. Lawton JS, Ellenbogen KA, Wood MA, et al. Sensing
lead-related complications in patients with transvenous
implantable cardioverter-defibrillators. Am J Cardiol
1996; 78:647-651.
14. Korte T, Jung W, Spehl S, et al. Incidence of ICD lead
related complications during long-term follow-up:
comparison of epicardial and endocardial electrode
systems. Pacing Clin Electrophysiol 1995; 18:2053-
2061.
15. Kowalski M, Ellenbogen KA, Wood MA, Friedman
PL. Implantable cardiac defibrillator lead failure or
myopotential oversensing An approach to the diagnosis
of noise on lead electrograms. Europace 2008; 10:914-
917.